Three-drug combination prolongs survival in men with metastatic, hormone-sensitive prostate cancer
A phase 3 trial demonstrates multiple benefits of adding the androgen-receptor inhibitor darolutamide to standard therapy.
Claire & John Bertucci
Contact Information
New Patients
(those who have not previously seen a doctor within the Mass General/Mass General Brigham)
Step 1. Obtain a medical record number (MRN).
Call the Mass General Registration & Referral Center to register as a patient and obtain an MRN: 866-211-6588.
Step 2. Call the Cancer Center new patient appointment line: 617-726-5130.
The schedulers can assist you in making the first available appointment with the appropriate physician. To help your call go smoothly, please have ready your:
Existing Patients
Call the Genitourinary Center scheduling line: 617-724-5197. They will connect you with your treatment team.
Support the Center Genitourinary Cancers
With your support, the team at the Claire and John Bertucci Center for Genitourinary Cancers is able maintain their commitment to quality patient care and advancing discoveries. Make a gift.
The Claire and John Bertucci Center for Genitourinary (GU) Cancers at Mass General Cancer Center is one of the largest and most experienced centers in New England for the treatment of genitourinary cancers. Many of the advanced diagnostic and therapeutic approaches available here are offered at only a few other centers nationwide.
We offer comprehensive, multidisciplinary care for patients with cancers of the:
Each patient in our program is cared for by a multidisciplinary team of experts who specialize in the diagnosis and treatment of genitourinary cancers, including medical oncologists, urologic surgeons, and radiation oncologists, as well as pathologists and radiologists. We work together with the patient and the referring physician throughout treatment to ensure the best possible outcomes.
We also offer a wide range of free educational programs and support services designed to address the physical, psychological and spiritual needs of patients and their families.
We lead the way in developing advanced imaging and diagnostic technologies and cancer therapies, including complex and minimally invasive surgical procedures and novel chemotherapy agents specifically designed to target individual cancers. Our experienced radiation oncology team are renowned for their expertise in using advanced radiation therapies to treat genitourinary cancers, including intensity-modulated radiation therapy and proton therapy.
Our coordinated team of genitourinary cancer specialists, including urologic surgeons, radiation oncologists, medical oncologists, diagnostic radiologists, pathologists and urologists, work together to develop a treatment plan tailored to each patient.
Learn more about Mass General's Department of Urology.
Learn about the Genitourinary Program in the Dept of Radiation Oncology.
Learn about our prostate cancer treatment program.
We help to identify families that may have a hereditary predisposition to prostate cancer.
Learn about our bladder cancer treatment program.
Learn about our kidney cancer treatment program.
Learn about our testicular cancer treatment program.
Our team provides evidenced based, expert nutrition counseling to patients & families.
We offer a variety of education and support resources to help you and your family.
Search the Cancer Center's open clinical trials.
Mass General has the only proton therapy site in all of New England, with two proton therapy centers.
Our support programs can help patients and their families cope with the challenges of a cancer diagnosis.
A phase 3 trial demonstrates multiple benefits of adding the androgen-receptor inhibitor darolutamide to standard therapy.
Contact us to make an appointment or to learn more about our programs.